Articles On Telix Pharmaceuticals (ASX:TLX)

The All Ordinaries index may be racing higher this month, but its 11% gain pales in comparison to some of the gains being made in November. Three All Ords shares that have been on fire this month are listed below. Here’s why they are rocke...

Telix Pharmaceuticals (ASX:TLX) has filed a new drug application with the US FDA for its radiopharmaceutical targeting ProstateSpecific Membrane Antigen for the imaging of prostate cancer using Positron Emission Tomography.

Summary ASX-listed biopharmaceutical company Telix Pharmaceuticals has received the FDA green light for its TLX591-CDx kit NDA. The biopharmaceutical company also added a priority review request in the NDA submission with the result an...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to record another strong gain. The benchmark index is currently up 1.1% to 6,639.2 points. Four shares that are climbing more than most today are listed below. Here’s...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are rocketing higher this morning after the company announced the United States Food and Drug Administration (FDA) approved its new drug application (NDA) for a prostate cancer imaging product. I...

Tom Bleakley, BW Equities BUY RECOMMENDATIONS Telix Pharmaceuticals (TLX)   This research and development oncology company has lodged an application to the US Food and Drug Administration for its lead prostate cancer imaging technology. It...

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a very strong gain. At the time of writing, the benchmark index is up a sizeable 2.3% to 6,088.4 points. Four shares that have failed to follow the market highe...

Telix Pharmaceuticals (ASX:TLX) has entered a strategic commercial partnership with China Grand Pharmaceutical and Healthcare Holdings for its portfolio of Molecularly-Targeted Radiation products.

The Melbourne-headquartered biopharmaceutical company is focused on developing a portfolio of clinical-stage oncology products that address significant unmet medical needs in prostate, kidney and brain cancer.

The S&P/ASX 200 Index (ASX: XJO) started the week in fine form and charged higher on Monday. The benchmark index rose 0.4% to end at 5,951.3 points. Four shares that climbed more than most today are listed below. Here’s why they storme...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price has started the week with a bang, rocketing by more than 30% today in welcome news for shareholders. Telix released a positive announcement during mid-afternoon trade, sending its shares...

Here’s the kind of late Friday afternoon announcement anyone who’s left paying attention loves to still be in the office for: “1st Group Limited (ASX:1ST) is pleased to announce it has entered into a strategic commercial partnership with Af...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is dropping lower and on course to end its winning streak. The benchmark index is currently down 0.4% to 5,917.6 points. Four shares that have not let that hold them back today are...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price has been a strong performer on Tuesday. In morning trade the clinical-stage biopharmaceutical company’s shares jumped 8% to $1.78. This leaves the Telix share price within sight of its 5...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to finish the week on a very positive note. The benchmark index is currently up a sizeable 1.6% to 5,971.5 points. Four shares that have failed to follow the market hi...

It has been a disappointing day of trade for the S&P/ASX 200 Index (ASX: XJO) on Thursday. At the time of writing, the benchmark index is down 1% to 5,869.3 points. Four shares that have not let that hold them back are listed below. He...

The market may be dropping lower today but that hasn’t stopped the Telix Pharmaceuticals Ltd (ASX: TLX) share price from charging higher. In morning trade the biopharmaceutical company’s shares are up 3.5% to $1.82. Why is the Telix share...

Telix Pharmaceuticals (ASX:TLX) has submitted a New Drug Application to the US FDA for its radiopharmaceutical targeting Prostate-Specific Membrane Antigen for the imaging of prostate cancer using Positron Emission Tomography.

Nuclear oncology company Telix Pharmaceuticals (ASX:TLX) says the first two patients with advanced lung or ovarian cancer have been dosed ... Read More The post First patients dosed in trial of Telix’s cancer imaging therapy appeared first...

I think the healthcare sector is a great place to look for buy and hold options. This is because in this sector you’ll find a number of companies that have the potential to grow significantly in the future thanks to favourable tailwinds an...

03 Sep 2020 - Telix Pharmaceuticals (ASX:TLX) has entered into a strategic collaboration agreement with California-based Varian Medical Systems.

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to record another strong gain. At the time of writing the benchmark index is up 1% to 6,121.7 points. Four shares that are climbing more than most today are listed below....

Jobkeeper subsidies will make up two thirds of dental group 1300 Smiles’ (ASX:ONT) final dividend at 12.5c payout. The company has maintained its fully franked final dividend at 12.5c, paying out a total of $2.96m to investors. The company...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The pundit...

One area of the share market which I believe is home to a number of promising small caps is the healthcare sector. Thanks to positive tailwinds and their impressive technology and products, I believe there are companies at this side of the...

It has been a busy day of quarterly update releases on the Australian share market. And while the likes of Bubs Australia Ltd (ASX: BUB) and Sezzle Inc (ASX: SZL) may have stolen the headlines, they weren’t the only companies releasing upd...

Telix Pharmaceuticals (ASX:TLX) says it has entered into a strategic collaboration agreement with US-based RefleXion Medical.

Pharmaceutical company Althea Group (ASX:AGH) had some interesting distribution news, announcing the Australian-first launch of an online channel for its medicinal cannabis products. The company says its Althea Concierge service, which has...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Victoria h...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price has jumped by 16.02% today on the back of a market announcement released this morning. The announcement confirmed the company has received a ‘Breakthrough Therapy’ (BT) designation for i...

01 Jul 2020 - Telix Pharmaceuticals (ASX:TLX) reports that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy (BT) designation for Telix’s renal cancer imag…

The S&P/ASX 200 Index (ASX: XJO) is on course to start the new financial year with a solid gain. At the time of writing the benchmark index is up 0.65% to 5,936.2 points. Four shares that have climbed more than most today are listed be...

Clinical-stage biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) has received confirmation from the FDA that its kidney cancer imaging product TLX250-CDx had been granted breakthrough therapy (BT) designation. The company claims to...

ShareCafeHidden Gems Webinar Recap – MMM, NCZ, ALC, TLX We continue to unearth micro and small-cap companies as part of our Hidden Gems webinar series. Catch up on the most recent edition with presentations from Marley Spoon AG (ASX:MMM), N...

Telix Pharmaceuticals (US) Inc, a subsidiary of Telix Pharmaceuticals Limited (ASX: TLX) announced on Friday that it has entered into a commercial distribution agreement with Boca Raton-based Pharmalogic Holdings Corp. (Pharmalogic) to prov...

15 May 2020 - Telix Pharmaceuticals (ASX:TLX) has entered into a commercial distribution agreement with Boca Raton-based Pharmalogic.

One area of the market that I think is a good place to look for buy and hold options is the small end of the healthcare sector. I think here you’ll find a number of companies that have the potential to grow significantly in the future than...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is on watch this morning following an announcement that it has received a major research grant for the development of drugs for a range of cancers. At the time of writing, Telix shares a...

The market carnage is certainly proving a great buying opportunity for directors, with even more last week, compared to the week before, scrambling to top up their holdings. Stockhead found 19 directors trades over $100,000 among ASX small...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is trading slightly higher on Tuesday after the release of a positive update. At the time of writing the clinical-stage biopharmaceutical company’s shares are up 0.5% to $1.52. This comp...

Jumbo Interactive (ASX:JIN) has added MS (Multiple Sclerosis) Queensland to its cohort of charity lottery clients. MS Queensland has bought a five-year licence for Jumbo’s online lottery software-as-a-service (SaaS) to set up a customised s...

Telix Pharmaceuticals (TLX) has received approval from the U.S. Food and Drug Administration for the ZIRCON study The ZIRCON study is an international Phase III study to evaluate the utility of Telix’s product which treats clear cell rena...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price has been a strong performer on Thursday. In morning trade the clinical-stage biopharmaceutical company’s shares are up 3.5% to $1.50. Why is the Telix Pharmaceuticals share price chargin...

You may have heard the saying “it’s not brain surgery” in the context of trying to prove something easy. Well there is a reason  — our brains are among the most difficult parts of our body to treat. There are a few ASX small caps trying to...

The health sector was the most successful sector on the ASX in 2019. Various small caps made several breakthroughs including with nerve damage and macular degeneration. While cancer remains one fish that has yet to be fried there are small...

Telix Pharmaceuticals (TLX) has submitted a clinical briefing package to the U.S. FDA for its prostate cancer treating drug The company has also completed the additional manufacturing and product release analytics that were recommended by...

Telix Pharmaceuticals (TLX) has submitted a phase 3 Investigational New Drug application to the U.S. FDA for its antibody-based imaging agent This applications forms part of the international phase 3 ZIRCON study which is expected to begi...

Invion (ASX:IVX) may have a new Chinese partner to help get its cosmetics business off the ground. The company told shareholders this morning it signed an MoU with Pavay Biotech, an established provider of dermatology treatment products in...